Our single-use bioreactor system engineering and cell culture scale-up solutions deliver integrated, risk-aligned bioprocess engineering services designed to accelerate the translation of cell culture workflows from lab-scale development through pilot campaigns and into commercial biomanufacturing. This offering centres on custom-engineered single-use bioreactor assemblies paired with scalable process development strategies, tailored for mammalian cell, microbial and advanced cell culture applications across biopharmaceuticals, vaccines and synthetic biology. We embed process scalability, sensor compatibility and closed-system contamination control into the mechanical design from the conceptual phase, eliminating common bottlenecks encountered during traditional scale-up, while aligning every design decision with cGMP expectations to support seamless regulatory progression of biologic drug candidates.
The full scope covers single-use bioreactor skid design, disposable bag and fluid path engineering, integration of single-use pH, dissolved oxygen and temperature sensors, agitation and sparging system optimisation, alongside computational modelling of mass transfer, shear stress and mixing performance across working volume scales. Our engineering team conducts comprehensive process characterisation and scale-up factor analysis to preserve critical process parameters when transferring culture conditions from small-scale vessels to larger production units. Deliverables include detailed P&ID schematics, equipment URS packages, FAT/SAT execution, IQ/OQ qualification frameworks and process transfer documentation, built to comply with global biopharmaceutical standards and supporting both fed-batch and perfusion cell culture modalities.
Engineered single-use bioreactor platforms drastically reduce cross-contamination risk and eliminate the resource-intensive cleaning, cleaning validation and SIP cycles required for conventional stainless steel bioreactor infrastructure. Precision hydrodynamic modelling ensures consistent mixing, gas transfer and shear profiles across scale tiers, minimising variability in cell viability, productivity and product quality during process scale transfer. Modular skid architecture enables rapid deployment, flexible reconfiguration between campaigns and reduced turnaround time between batches. Closed sensor and fluid path integration maintains aseptic boundaries throughout operations, while digital data acquisition delivers continuous, audit-ready process records for batch traceability and regulatory inspection readiness.
These bioreactor engineering and scale-up solutions support biopharma sponsors, CDMOs and synthetic biology developers manufacturing monoclonal antibodies, recombinant proteins, viral vectors and vaccine antigens. Beyond system design and fabrication, our service portfolio includes process development consultation, scale-up risk assessment, on-site commissioning, operator training and post-implementation technical support. Our holistic approach de-risks cell culture process transfer, shortens the timeline from clinical proof-of-concept to commercial production, optimises capital and operational expenditure, and establishes robust, compliant single-use biomanufacturing infrastructure for global product commercialisation.
